Prostate Cancer Phase 1 Lattice Extreme Ablative Dose (LEAD) Trial: Feasibility and Acute Toxicity

Journal article

International journal of radiation oncology, biology, physics, Vol.90(1), pp.S455-S455

2014-09

Metrics

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.1297 Proton Therapy
Web Of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Prostate Cancer Phase 1 Lattice Extreme Ablative Dose (LEAD) Trial: Feasibility and Acute Toxicity
Creators: A Pollack
M Abramowitz
E Bossart
I Reis
C Lynne
M Jorda
V Casillas
A Ishkanian
R Stoyanova
Publication Details: International journal of radiation oncology, biology, physics, Vol.90(1), pp.S455-S455
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Pathology; UMMG Department of Public Health Sciences Research; UMMG Department of Urology; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600234702976